Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by Stockspawkon Feb 05, 2019 12:19pm

118 Views

Post# 29321078

RE:RE:Bids And Asks

Just my opinion, but at these prices, I would be grabbing whatever I can. I think they are setup for success in the very near future. Yes this isn't what I wanted to see, but I feel that this was a neccisary step in order to keep the progression train going. As we get closer and closer the results, you will see the SP climb and I think that the day they do actually come out, we will be well north of $1. Again just my opinion. Thoughts?

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute